<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="xsl/EstiloXSL.xsl"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="3.0" article-type="research-article" xml:lang="en">
	<front>
		<journal-meta>
			<journal-id journal-id-type="nlm-ta">Arq Gastroenterol</journal-id>
			<journal-title-group>
				<journal-title>Arquivos de Gastroenterologia</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Arq. Gastroenterol.</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="ppub">0004-2803</issn>
			<publisher>
				<publisher-name>Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia - IBEPEGE , Colégio Brasileiro de Cirurgia Digestiva - CBCD , Sociedade Brasileira de Motilidade Digestiva - SBMD , Federação Brasileira de Gastroenterologia - FBG, Sociedade Brasileira de Hepatologia - SBH, Sociedade Brasileira de Endoscopia Digestiva - SOBED</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">S0004-28032012000100009</article-id>
			<article-id pub-id-type="doi">10.1590/S0004-28032012000100009</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Original Article</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title xml:lang="en">Prevalence of upper digestive endoscopy and gastric histopathology findings in morbidly obese patients </article-title>
				<trans-title-group xml:lang="pt">
					<trans-title>Prevalência de achados gástricos endoscópicos e histopatológicos em pacientes obesos</trans-title>
				</trans-title-group>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Dietz</surname>
						<given-names>Judite</given-names>
					</name>
					<xref ref-type="aff" rid="aff1">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Ulbrich-Kulcynski</surname>
						<given-names>Jane Maria</given-names>
					</name>
					<xref ref-type="aff" rid="aff2">2</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Souto</surname>
						<given-names>Katia Elisabete Pires</given-names>
					</name>
					<xref ref-type="aff" rid="aff3">3</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Meinhardt</surname>
						<given-names>Nelson Guardiola</given-names>
					</name>
					<xref ref-type="aff" rid="aff4">4</xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>1</label>Division of Endoscopy, HNSC</aff>
			<aff id="aff2">
				<label>2</label>Department of Pathology, Universidade Federal do Rio Grande do Sul (UFRGS)</aff>
			<aff id="aff3">
				<label>3</label>Division of Endocrinology, HNSC</aff>
			<aff id="aff4">
				<label>4</label>Division of Bariatric Surgery, HNSC, Porto Alegre, RS, Brazil</aff>
			<author-notes>
				<corresp>
					<bold>Correspondence</bold>:  Dr. Judite Dietz Rua Augusto L. Lima, 129 - ap. 701 90470-120 - Porto Alegre, RS, Brazil E-mail: <email>judi60@gmail.com</email>
				</corresp>
				<fn fn-type="financial-disclosure">
					<p>Financial support: no.</p>
				</fn>
				<fn fn-type="conflict">
					<p>The authors declare that they have no conflicts of interest</p>
				</fn>
			</author-notes>
			<pub-date pub-type="epub-ppub">
				<season>Jan-Mar</season>
				<year>2012</year>
			</pub-date>
			<volume>49</volume>
			<issue>1</issue>
			<fpage>52</fpage>
			<lpage>55</lpage>
			<history>
				<date date-type="received">
					<day>31</day>
					<month>01</month>
					<year>2011</year>
				</date>
				<date date-type="accepted">
					<day>01</day>
					<month>09</month>
					<year>2011</year>
				</date>
			</history>
			<permissions>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
					<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
				</license>
			</permissions>
			<abstract xml:lang="en">
				<sec>
					<title>CONTEXT:</title>
					<p> The prevalence of obesity has been increasing in modern society. Roux-en-y gastric bypass is a bariatric surgery that involves the exclusion of significant part of the stomach. Atrophy, intestinal metaplasia and gastric cancer have been associated with infection by <named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content>.  </p>
				</sec>
				<sec>
					<title> OBJECTIVES:</title>
					<p> To evaluate the presence of endoscopy findings and histological changes in morbid obese patients for the presence of inflammatory cells, inflammatory activity, lymphoid hyperplasia, <named-content content-type="scientific-name">
							<italic>H</italic>. <italic>pylori</italic>
						</named-content> infection, atrophy and intestinal metaplasia in the gastric mucosa. </p>
				</sec>
				<sec>
					<title>METHODS:</title>
					<p> Upper digestive endoscopy and gastric histopathological were studied in 126 obese patients in the preoperative evaluation for bariatric surgery. </p>
				</sec>
				<sec>
					<title>RESULTS:</title>
					<p> Upper digestive endoscopy abnormalities were diagnosed in 73/126 (57.9%) patients. In three patients (2.4%) the upper gastrointestinal endoscopy diagnosed gastric ulcer and one patient (0.8%) had duodenal ulcer. The histopathological from gastric biopsies of these obese patients showed 65.1% of mucosa inflammation, inflammatory activity in 50.0%, infection by <named-content content-type="scientific-name">
							<italic>H</italic>. <italic>pylori</italic>
						</named-content> in 53.2%, lymphoid hyperplasia in 50.0% and atrophy and/or intestinal metaplasia in 16.7%. </p>
				</sec>
				<sec>
					<title>CONCLUSIONS:</title>
					<p> In present study, with routine preoperative upper gastrointestinal endoscopy and histopathological examination, were detected 57.9% patients with endoscopy abnormalities, high prevalence of infection by <italic>H</italic>. <italic>pylori</italic> (53%) and 16.7% of gastric atrophy and/or intestinal metaplasia.</p>
				</sec>
			</abstract>
			<trans-abstract xml:lang="pt">
				<sec>
					<title>CONTEXT:</title>
					<p> A prevalência de obesidade tem aumentado significativamente nos últimos anos. Bypass gástrico em Y-de-Roux, uma das técnicas cirúrgicas realizadas no tratamento da obesidade, envolve exclusão de parte do estômago. Atrofia, metaplasia intestinal e câncer gástrico têm sido associados com infecção pelo <named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>.</named-content>
					</p>
				</sec>
				<sec>
					<title> OBJETIVOS:</title>
					<p> Avaliar a prevalência de achados endoscópicos e alterações histopatológicas em pacientes obesos mórbidos em relação à presença de células inflamatórias, atividade inflamatória, hiperplasia linfóide, infecção pelo <named-content content-type="scientific-name">
							<italic>H</italic>. <italic>pylori</italic>
						</named-content>, atrofia e metaplasia intestinal na mucosa gástrica.  </p>
				</sec>
				<sec>
					<title>MÉTODOS:</title>
					<p> Achados na endoscopia digestiva alta e histopatologia gástrica foram analisados em 126 pacientes obesos na avaliação pré-operatória de cirurgia bariátrica. </p>
				</sec>
				<sec>
					<title>RESULTADOS:</title>
					<p> Anormalidades endoscópicas do trato digestivo superior foram diagnosticadas em 73/126 pacientes, com três pacientes (2,4%) apresentando úlcera gástrica e um paciente (0,8%) com úlcera duodenal. A histopatologia das biopsias gástricas dos obesos estudados revelou 65,1% de processo inflamatório na mucosa, atividade inflamatória em 50,0%; infecção pelo <named-content content-type="scientific-name">
							<italic>H</italic>. <italic>pylori</italic>
						</named-content> em 53,2%, hiperplasia linfóide em 50,0%, atrofia e/ou metaplasia intestinal em 16,7%. </p>
				</sec>
				<sec>
					<title>CONCLUSÕES:</title>
					<p> No presente estudo, através de endoscopia digestiva alta e histopatologia de biopsias gástricas, foram detectados 57,9% de pacientes com anormalidades endoscópicas, prevalência de infecção pelo <named-content content-type="scientific-name">
							<italic>H</italic>. <italic>pylori</italic>
						</named-content> em 53% e atrofia e/ou metaplasia intestinal em 16,7%.</p>
				</sec>
			</trans-abstract>
			<kwd-group xml:lang="en">
				<kwd>Obesity, morbid</kwd>
				<kwd>Gastric bypass</kwd>
				<kwd>Endoscopy gastrointestinal</kwd>
				<kwd>Helicobacter infections</kwd>
			</kwd-group>
			<kwd-group xml:lang="pt">
				<kwd>Obesidade mórbida</kwd>
				<kwd>Derivação gástrica</kwd>
				<kwd>Endoscopia gastrointestinal</kwd>
				<kwd>Infecções por helicobacter</kwd>
			</kwd-group>
			<counts>
				<table-count count="3"/>
				<ref-count count="40"/>
				<page-count count="4"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<sec sec-type="intro">
			<title>INTRODUCTION</title>
			<p>Obesity is considered to be a growing problem in modern society and its prevalence has been increasing in both developed and developing countries<sup>(<xref ref-type="bibr" rid="r03">3</xref>)</sup>.</p>
			<p>Most types of bariatric surgery include resection, sutures or partial stomach exclusion. The most frequent bariatric surgery is the Roux-en-Y gastric bypass (RYGBP), which involves partial exclusion of the stomach<sup>(<xref ref-type="bibr" rid="r03">3</xref>)</sup>.</p>
			<p>Mucosal alterations after vertical banded RYGBP have not been clearly evaluated because the excluded stomach is not easily reached by conventional endoscopy<sup>(<xref ref-type="bibr" rid="r18">18</xref>, <xref ref-type="bibr" rid="r21">21</xref>, <xref ref-type="bibr" rid="r39">39</xref>)</sup>.</p>
			<p>Infection by the <named-content content-type="scientific-name">
					<italic>Helicobacter</italic>
					<italic>pylori</italic>
				</named-content> (<named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content>) causes inflammation of the gastric mucosa, which can develop atrophy, intestinal metaplasia, dysplasia and cancer<sup>(<xref ref-type="bibr" rid="r03">3</xref>, <xref ref-type="bibr" rid="r06">6</xref>, <xref ref-type="bibr" rid="r27">27</xref>)</sup>. The eradication of the <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> leads to a regression of the inflammatory process of the gastric mucosa, the same does not happen in the more advanced stages, with the presence of atrophy and intestinal metaplasia<sup>(<xref ref-type="bibr" rid="r08">8</xref>, <xref ref-type="bibr" rid="r13">13</xref>, <xref ref-type="bibr" rid="r24">24</xref>, <xref ref-type="bibr" rid="r28">28</xref>, <xref ref-type="bibr" rid="r40">40</xref>)</sup>.</p>
			<p>The present study aims to evaluate the prevalence of endoscopic findings and gastric histopathological alterations in morbidly obese patients. The histopathological alterations comprise presence of inflammation cells, inflammatory activity, presence of lymphoid hyperplasia, infection by the <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>,</named-content> atrophy and intestinal metaplasia in the gastric mucosa.</p>
		</sec>
		<sec sec-type="methods">
			<title>METHODS</title>
			<p>Consecutive study conducted in outpatient service with 126 morbidly obese patients [body mass index (BMI) = &gt;40 kg/m2] or obese patients (with BMI between 35-40 kg/m2) with indication for bariatric surgery by significant co-morbidities. Upper gastrointestinal endoscopy (UGI) and gastric biopsies was required in the preoperative period. The patients had not undergone UGI or treatment to eradicate <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylory</italic>
				</named-content> previously. The study was approved by the Ethics Committee of Hospital Conceição, Porto Alegre, RS, Brazil, and all patients gave informed consent prior to their inclusion in the study. The upper endoscopies were realized by the same gastroenterologist with a video-endoscope Fujinon series 400. Four gastric biopsies were carried out, two in the body and two in the antrum, always in the greater gastric curvature. Los Angeles and Sydney classification were used in the endoscopic analysis of esophagitis and gastritis<sup>(<xref ref-type="bibr" rid="r01">1</xref>, <xref ref-type="bibr" rid="r08">8</xref>)</sup>.</p>
			<p>Alterations of the gastric mucosa were classified by the pathologist as an inflammatory process through the presence of lymphocytic and plasmocytic cells and inflammatory activity through the presence of neutrophils. Lymphoid hyperplasia, presence of <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content>, epithelial atrophy and intestinal metaplasia were other parameters analyzed.</p>
		</sec>
		<sec sec-type="results">
			<title>RESULTS</title>
			<p>Female population predominated (104 patients - 82.5%). The mean age was 42.08 years and the mean BMI was 51.2 kg/m² (standard deviation ± 9.34).</p>
			<p>Upper digestive diseases (UGI) were diagnosed in 73 patients (57.9%) through endoscopy, being esophagitis and/or hiatal hernia in 31 cases (24.6%); exsudative/enanthematous gastritis in 6 patients (4.8%); exsudative/enanthematous erosive gastritis in 38 patients (30.2%); gastric ulcer in 3 (2.4%); duodenal ulcer in 1 obese (0.8%). In 53 (42.1%) patients the endoscopy was normal (<xref ref-type="table" rid="t01">Table 1</xref>). Some patients had more than one lesion at UGI.</p>
			<p>
				<table-wrap id="t01">
					<label>TABLE 1</label>
					<caption>
						<title>Upper digestive endoscopic findings (n = 126)</title>
					</caption>
					<table frame="hsides" rules="groups" width="50%">
						<thead style="border-bottom: thin solid; border-top: thin solid; border-color: #000000">
							<tr>
								<th align="left">Diagnosis</th>
								<th>Patients</th>
								<th>Percentage</th>
							</tr>
						</thead>
						<tbody style="border-color: #000000; border-bottom: thin solid">
							<tr>
								<td>Esophagitis and/or hiatal hernia</td>
								<td align="center">31</td>
								<td align="center">24.6%</td>
							</tr>
							<tr>
								<td>Exudative/enanthematous gastritis</td>
								<td align="center">6</td>
								<td align="center">4.8%</td>
							</tr>
							<tr>
								<td>Erosive gastritis</td>
								<td align="center">38</td>
								<td align="center">30.2%</td>
							</tr>
							<tr>
								<td>Gastric ulcer</td>
								<td align="center">3</td>
								<td align="center">2.4%</td>
							</tr>
							<tr>
								<td>Duodenal ulcer</td>
								<td align="center">1</td>
								<td align="center">0.8%</td>
							</tr>
							<tr>
								<td>Normal endoscopy</td>
								<td align="center">53</td>
								<td align="center">42.1%</td>
							</tr>
						</tbody>
					</table>
				</table-wrap>
			</p>
			<p>The prevalence of inflammatory cells in the gastric mucosa was found in 82 (65.1%) patients, inflammatory activity in 63 (50.0%), lymphoid hyperplasia in 63 (50.0%), infection by <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> in 67 (53.2%), epithelial atrophy and/or intestinal metaplasia in 21 (16.7%) and normal gastric histopathological in 33 (26.2%) patients (<xref ref-type="table" rid="t02">Table 2</xref>).</p>
			<p>
				<table-wrap id="t02">
					<label>TABLE 2</label>
					<caption>
						<title>Histological analysis of gastric mucosa (n = 126)</title>
					</caption>
					<table frame="hsides" rules="groups" width="50%">
						<thead style="border-bottom: thin solid; border-top: thin solid; border-color: #000000">
							<tr>
								<th align="left">Diagnosis</th>
								<th>Patients</th>
								<th>Percentage</th>
							</tr>
						</thead>
						<tbody style="border-color: #000000; border-bottom: thin solid">
							<tr>
								<td>Mucosa inflammation</td>
								<td align="center">82</td>
								<td align="center">65.1%</td>
							</tr>
							<tr>
								<td>Inflammatory activity</td>
								<td align="center">63</td>
								<td align="center">50.0%</td>
							</tr>
							<tr>
								<td>Lymphoid hyperplasia</td>
								<td align="center">63</td>
								<td align="center">50.0%</td>
							</tr>
							<tr>
								<td>
									<italic>Helicobacter pylori</italic>
								</td>
								<td align="center">67</td>
								<td align="center">53.2%</td>
							</tr>
							<tr>
								<td>Epithelial atrophy and/or intestinal metaplasia</td>
								<td align="center">21</td>
								<td align="center">16.7%</td>
							</tr>
							<tr>
								<td>Normal</td>
								<td align="center">33</td>
								<td align="center">26.2%</td>
							</tr>
						</tbody>
					</table>
				</table-wrap>
			</p>
			<p>Five (8.5%) of the 59 patients with negative results for <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> had gastric intestinal metaplasia or epithelial atrophy.</p>
			<p>In these obese patients, the gastric histopathological parameters studied was not statistical different (<italic>P</italic>&lt;0.05%) in the patients with stomach or duodenum abnormalities at UGI, comparatively with patients without any gastroduodenal abnormalities at UGI (<xref ref-type="table" rid="t03">Table 3</xref>), except the parameter inflammatory activity (<xref ref-type="table" rid="t03">Table 3</xref>). The diagnosis of inflammatory activity in gastric mucosa was greater in the group of normal UGI when compared with patients with UGI findings (<italic>P</italic> = 0.04) (<xref ref-type="table" rid="t03">Table 3</xref>).</p>
			<p>
				<table-wrap id="t03">
					<label>TABLE 3</label>
					<caption>
						<title>Obese patients with endoscopic abnormalities in stomach and/or duodenum versus obese with normal stomach and/or duodenum at endoscopy. Gastric histopathological analysis</title>
					</caption>
					<table frame="hsides" rules="groups" width="95%">
						<thead style="border-bottom: thin solid; border-top: thin solid; border-color: #000000">
							<tr>
								<th rowspan="3"/>
								<th colspan="2" valign="bottom">Abnormal stomach/duodenum</th>
								<th colspan="2" valign="bottom">Normal stomach/duodenum</th>
								<th rowspan="3">Odds ratio
					  (95%CI)</th>
								<th rowspan="3">
									<italic>P</italic>-value</th>
							</tr>
							<tr style="border-bottom: thin solid">
								<th colspan="2" valign="top">(n = 46)</th>
								<th colspan="2" valign="top">(n = 80)</th>
							</tr>
							<tr>
								<th>n</th>
								<th>%</th>
								<th>n</th>
								<th>%</th>
							</tr>
						</thead>
						<tbody style="border-color: #000000; border-bottom: thin solid">
							<tr>
								<td>Mucosal inflammation</td>
								<td align="center">48</td>
								<td align="center">60.0</td>
								<td align="center">34</td>
								<td align="center">73.9</td>
								<td align="center">0.52 (0.23-1.17)</td>
								<td align="center">0.08</td>
							</tr>
							<tr>
								<td>Inflammatory activity</td>
								<td align="center">35</td>
								<td align="center">43.8</td>
								<td align="center">28</td>
								<td align="center">60.9</td>
								<td align="center">0.50 (0.23-1.04)</td>
								<td align="center">0.04</td>
							</tr>
							<tr>
								<td>Lymphoid hyperplasia</td>
								<td align="center">40</td>
								<td align="center">50.0</td>
								<td align="center">23</td>
								<td align="center">50.0</td>
								<td align="center">1.00 (0.48-2.06)</td>
								<td align="center">0.57</td>
							</tr>
							<tr>
								<td>
									<italic>Helicobacter pylori</italic>
								</td>
								<td align="center">41</td>
								<td align="center">51.3</td>
								<td align="center">26</td>
								<td align="center">56.5</td>
								<td align="center">0.80 (0.38-1.67)</td>
								<td align="center">0.35</td>
							</tr>
							<tr>
								<td>Epithelial atrophy and/or intestinal metaplasia</td>
								<td align="center">15</td>
								<td align="center">18.8</td>
								<td align="center">6</td>
								<td align="center">13.0</td>
								<td align="center">1.53 (0.55-4.28)</td>
								<td align="center">0.28</td>
							</tr>
							<tr>
								<td>Normal</td>
								<td align="center">22</td>
								<td align="center">27.5</td>
								<td align="center">11</td>
								<td align="center">23.9</td>
								<td align="center">1.20 (0.52-2.78)</td>
								<td align="center">0.41</td>
							</tr>
						</tbody>
					</table>
					<table-wrap-foot>
						<fn id="TFN01t03">
							<p>CI = confidence interval</p>
						</fn>
					</table-wrap-foot>
				</table-wrap>
			</p>
		</sec>
		<sec sec-type="discussion">
			<title>DISCUSSION</title>
			<p>The prevalence of obese individuals in USA (defined as BMI&gt;30 kg/m2) has increased from 15.3% to 23.9% in the period of 1995 to 2005 and the prevalence of morbidly obese individuals (BMI&gt;40 kg/m2) was of 4.8% in 2005<sup>(<xref ref-type="bibr" rid="r04">4</xref>)</sup>.</p>
			<p>The most performed bariatric procedure is the RYGBP, which involves the exclusion of a significant part of the stomach. Lesions of the excluded stomach have been reported and the diagnosis of this possibility is difficult, onerous, not always available and, as a result of that, gastric diseases, such as ulcers and malignant neoplasms in the excluded stomach may not be diagnosed<sup>(<xref ref-type="bibr" rid="r18">18</xref>, <xref ref-type="bibr" rid="r21">21</xref>, <xref ref-type="bibr" rid="r39">39</xref>)</sup>.</p>
			<p>
				<named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> is associated to gastric diseases, such gastritis, ulcer, epithelial atrophy, intestinal metaplasia, lymphoma, adenocarcinoma<sup>(<xref ref-type="bibr" rid="r09">9</xref>, <xref ref-type="bibr" rid="r31">31</xref>)</sup>. The prevalence of infection caused by the <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> in Latin America is around 60%, varying from 30% to 90%<sup>(<xref ref-type="bibr" rid="r05">5</xref>)</sup>.</p>
			<p>
				<named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> causes inflammation of the gastric mucosa in all infected individuals<sup>(<xref ref-type="bibr" rid="r10">10</xref>)</sup>. This inflammation consists initially in recruitment of neutrophils, followed by lymphocytes, with later epithelial damage<sup>(<xref ref-type="bibr" rid="r15">15</xref>)</sup>. The chronic inflammatory process increases the turnover of epithelial cells and apoptosis (cellular death), evolving to epithelial atrophy and intestinal metaplasia<sup>(<xref ref-type="bibr" rid="r09">9</xref>)</sup>.</p>
			<p>The development of gastric cancer involves several stages and can start with chronic gastritis, atrophy, intestinal metaplasia, dysplasia and finally invasive cancer<sup>(<xref ref-type="bibr" rid="r06">6</xref>)</sup>. The World Health Organization concluded, in 1994, for the existence of epidemiological and histological evidences to classify the <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> as carcinogenic, group 1<sup>(<xref ref-type="bibr" rid="r16">16</xref>)</sup>. Studies have shown the increased incidence of gastric cancer in the population infected by the <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content>, as well as a positive correlation between intestinal metaplasia and stomach cancer<sup>(<xref ref-type="bibr" rid="r27">27</xref>, <xref ref-type="bibr" rid="r31">31</xref>, <xref ref-type="bibr" rid="r37">37</xref>)</sup>.</p>
			<p>Eradication of the <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> leads to a regression of the inflammation, reduction of cellular turnover, increase in the acid secretion, which are important factors for the prevention of gastric cancer<sup>(<xref ref-type="bibr" rid="r09">9</xref>, <xref ref-type="bibr" rid="r14">14</xref>, <xref ref-type="bibr" rid="r22">22</xref>, <xref ref-type="bibr" rid="r24">24</xref>)</sup>. Some studies have concluded for the irreversibility of the carcinogenic process, even with the eradication of the <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>,</named-content> basically when intestinal metaplasia of the stomach was present<sup>(<xref ref-type="bibr" rid="r13">13</xref>, <xref ref-type="bibr" rid="r14">14</xref>, <xref ref-type="bibr" rid="r20">20</xref>)</sup>.</p>
			<p>The incidence of stomach cancer is still now a frequent causes in the group of world malignant neoplasm, being an important cause of mortality<sup>(<xref ref-type="bibr" rid="r17">17</xref>)</sup>. Few cases of gastric cancer in the bypassed stomach have been described after RYGBP for morbid obesity<sup>(<xref ref-type="bibr" rid="r18">18</xref>, <xref ref-type="bibr" rid="r36">36</xref>)</sup>. Factors such as difficulty of access to the excluded stomach and the reduced number of patients with adequate follow-up after bariatric surgery can interfere in this analysis.</p>
			<p>The rationale for performing UGI in the candidates to bariatric surgery is to detect and treat lesions that might potentially lead to complications in the immediate postoperative period, or result in diseases in the months or years following RYGBP surgery<sup>(<xref ref-type="bibr" rid="r25">25</xref>, <xref ref-type="bibr" rid="r26">26</xref>)</sup>.</p>
			<p>Eradication of the <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> as a routine in the pre-operative of bariatric surgery is still debated and scarce researches were performed in regards the histology of gastric mucosa<sup>(<xref ref-type="bibr" rid="r02">2</xref>, <xref ref-type="bibr" rid="r07">7</xref>, <xref ref-type="bibr" rid="r11">11</xref>, <xref ref-type="bibr" rid="r23">23</xref>, <xref ref-type="bibr" rid="r25">25</xref>, <xref ref-type="bibr" rid="r26">26</xref>, <xref ref-type="bibr" rid="r30">30</xref>, <xref ref-type="bibr" rid="r33">33</xref>, <xref ref-type="bibr" rid="r34">34</xref>, <xref ref-type="bibr" rid="r35">35</xref>)</sup>.</p>
			<p>Mong et al.<sup>(<xref ref-type="bibr" rid="r25">25</xref>)</sup> studied 272 patients who were candidates to bariatric surgery, in which 33 (12%) showed lesions in the upper digestive tract. Endoscopic findings were: esophagitis in 3.7%; Barrett's esophagus in 3.7%; gastric ulcer and/or erosive gastritis in 3.2%; duodenal ulcer in 0.7% and gastric carcinoid tumor in 0.3%.</p>
			<p>Muñoz et al.<sup>(<xref ref-type="bibr" rid="r26">26</xref>)</sup> diagnosed UGI abnormalities in 46% in the obese patients, one of them with gastric cancer.</p>
			<p>Dutta et al.<sup>(<xref ref-type="bibr" rid="r11">11</xref>)</sup> found prevalence of gastric ulcer of 2.9%, identified histologically gastritis in 23.7% and <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> in 6.9% in the obese patients, finding that was not different from the control (non-obese) patients.</p>
			<p>Safatle-Ribeiro et al.<sup>(<xref ref-type="bibr" rid="r33">33</xref>)</sup> examined the excluded stomach in 40 patients by enteroscopy in an average of 78 months after surgery. In this study, an inflammatory process in the gastric mucosa was diagnosed in 100% of the cases, atrophy in 14%, intestinal metaplasia in 11.4 % and infection by the <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> in 20%. All cases of <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> infection in the excluded stomach also had the same infection in the gastric functional pouch.</p>
			<p>A review of the literature revealed that the preoperative prevalence of <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> ranges from 6.9% to 61.3% in obese patients undergoing bariatric surgery<sup>(<xref ref-type="bibr" rid="r02">2</xref>, <xref ref-type="bibr" rid="r11">11</xref>, <xref ref-type="bibr" rid="r12">12</xref>, <xref ref-type="bibr" rid="r19">19</xref>, <xref ref-type="bibr" rid="r23">23</xref>, <xref ref-type="bibr" rid="r29">29</xref>, <xref ref-type="bibr" rid="r30">30</xref>, <xref ref-type="bibr" rid="r32">32</xref>, <xref ref-type="bibr" rid="r38">38</xref>)</sup>.</p>
			<p>In the present study, there were 73 (57.9%) cases with abnormalities in upper digestive endoscopy and 53 (42.1%) patients with normal UGI. In 42 cases (33.3%) gastroduodenal abnormalities were diagnosed, like exudative/enanthematous gastritis, erosive gastritis, gastric or duodenal ulcers. Approximately 50% of the obese patients showed inflammatory activity and infection by the <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> and 16% had atrophy and/or intestinal metaplasia in gastric mucosa. The absence of <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> infection does not rule out gastric metaplasia or atrophy.</p>
			<p>The prevalence of <named-content content-type="scientific-name">
					<italic>H</italic>. <italic>pylori</italic>
				</named-content> infection and gastric atrophy and/or intestinal metaplasia in obese patients with gastric or duodenal lesions at endoscopy, comparatively with obese patients with normal stomach or duodenal at UGI, was not statistical different (<italic>P</italic>&lt;0.05).</p>
			<p>The long-term follow-up of patients submitted to RYGBP may probably clarify if histopathological abnormalities of the gastric mucosa diagnosed prior surgery could interfere in the postoperative complications or in risk of gastric cancer.</p>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>REFERENCES</title>
			<ref id="r01">
				<label>1</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Armstrong</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Bennett</surname>
							<given-names>JR</given-names>
						</name>
						<name>
							<surname>Blum</surname>
							<given-names>AL</given-names>
						</name>
						<name>
							<surname>Dent</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>De Dombal</surname>
							<given-names>FT</given-names>
						</name>
						<name>
							<surname>Galmiche</surname>
							<given-names>JP</given-names>
						</name>
						<name>
							<surname>Lundell</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Marguilies</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Richter</surname>
							<given-names>JE</given-names>
						</name>
						<name>
							<surname>Spechler</surname>
							<given-names>SJ</given-names>
						</name>
						<name>
							<surname>Tytgat</surname>
							<given-names>GN</given-names>
						</name>
						<name>
							<surname>Wallin</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">The endoscopic assessment of esophagitis: a progress report on observer agreement</article-title>
					<source xml:lang="en">Gastroenterology</source>
					<year>1996</year>
					<volume>111</volume>
					<fpage>85</fpage>
					<lpage>92</lpage>
				</element-citation>
			</ref>
			<ref id="r02">
				<label>2</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Azagury</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Domonceau</surname>
							<given-names>JM</given-names>
						</name>
						<name>
							<surname>Morel</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Chassot</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Huber</surname>
							<given-names>O</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Preoperative work-up in asymptomatic patients undergoing Roux-en-Y gastric bypass: is endoscopy mandatory? </article-title>
					<source xml:lang="en">Obes Surg</source>
					<year>2006</year>
					<volume>16</volume>
					<fpage>1304</fpage>
					<lpage>1311</lpage>
				</element-citation>
			</ref>
			<ref id="r03">
				<label>3</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Benotti</surname>
							<given-names>PN</given-names>
						</name>
						<name>
							<surname>Forse</surname>
							<given-names>RA</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">The role of gastric surgery in the multidisciplinary management of severe obesity</article-title>
					<source xml:lang="en">Am J Surg</source>
					<year>1995</year>
					<volume>169</volume>
					<fpage>361</fpage>
					<lpage>367</lpage>
				</element-citation>
			</ref>
			<ref id="r04">
				<label>4</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<collab>Centers for Disease Control and Prevention (CDC)</collab>
					</person-group>
					<article-title xml:lang="en">State-specific prevalence of obesity among adults-United States, 2005</article-title>
					<source xml:lang="en">MMWR Morb Mortal Wkly Rep</source>
					<year>2006</year>
					<volume>55</volume>
					<fpage>985</fpage>
					<lpage>988</lpage>
				</element-citation>
			</ref>
			<ref id="r05">
				<label>5</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Coelho</surname>
							<given-names>LG</given-names>
						</name>
						<name>
							<surname>León-Barúa</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Quigley</surname>
							<given-names>EM</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Latin-American Consensus Conference on <named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content> infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE) </article-title>
					<source xml:lang="en">Am J Gastroenterol</source>
					<year>2000</year>
					<volume>95</volume>
					<fpage>2688</fpage>
					<lpage>2691</lpage>
				</element-citation>
			</ref>
			<ref id="r06">
				<label>6</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Correa</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention</article-title>
					<source xml:lang="en">Cancer Res</source>
					<year>1992</year>
					<volume>52</volume>
					<fpage>6735</fpage>
					<lpage>6740</lpage>
				</element-citation>
			</ref>
			<ref id="r07">
				<label>7</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>de Moura Almeida</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Cotrim</surname>
							<given-names>HP</given-names>
						</name>
						<name>
							<surname>Santos</surname>
							<given-names>AS</given-names>
						</name>
						<name>
							<surname>Bitencourt</surname>
							<given-names>AG</given-names>
						</name>
						<name>
							<surname>Barbosa</surname>
							<given-names>DB</given-names>
						</name>
						<name>
							<surname>Lobo</surname>
							<given-names>AP</given-names>
						</name>
						<name>
							<surname>Rios</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Alves</surname>
							<given-names>E</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Preoperative upper gastrointestinal endoscopy in obese patients undergoing bariatric surgery: is it necessary?</article-title>
					<source xml:lang="en">Surg Obes Relat Dis</source>
					<year>2008</year>
					<volume>4</volume>
					<page-range>144-9;discussion 150-1</page-range>
				</element-citation>
			</ref>
			<ref id="r08">
				<label>8</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Dixon</surname>
							<given-names>MF</given-names>
						</name>
						<name>
							<surname>Genta</surname>
							<given-names>RM</given-names>
						</name>
						<name>
							<surname>Yardley</surname>
							<given-names>JH</given-names>
						</name>
						<name>
							<surname>Correa</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Classification and grading of gastritis. The updated Sydney System. International Workshop on Histopathology of Gastritis, Houston 1994</article-title>
					<source xml:lang="en">Am J Surg Pathol</source>
					<year>1996</year>
					<volume>20</volume>
					<fpage>1161</fpage>
					<lpage>1181</lpage>
				</element-citation>
			</ref>
			<ref id="r09">
				<label>9</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Dixon</surname>
							<given-names>MF</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia</article-title>
					<source xml:lang="en">Gut</source>
					<year>2001</year>
					<volume>49</volume>
					<fpage>2</fpage>
					<lpage>4</lpage>
				</element-citation>
			</ref>
			<ref id="r10">
				<label>10</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Dooley</surname>
							<given-names>CP</given-names>
						</name>
						<name>
							<surname>Cohen</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Fitzgibbons</surname>
							<given-names>PL</given-names>
						</name>
						<name>
							<surname>Bauer</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Appleman</surname>
							<given-names>MD</given-names>
						</name>
						<name>
							<surname>Perez-Perez</surname>
							<given-names>GI</given-names>
						</name>
						<name>
							<surname>Blaser</surname>
							<given-names>MJ</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Prevalence of <named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content> infection and histologic gastritis in asymptomatic persons</article-title>
					<source xml:lang="en">N Engl J Med</source>
					<year>1989</year>
					<volume>321</volume>
					<fpage>1562</fpage>
					<lpage>1566</lpage>
				</element-citation>
			</ref>
			<ref id="r11">
				<label>11</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Dutta</surname>
							<given-names>SK</given-names>
						</name>
						<name>
							<surname>Arora</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Kireet</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Bashandy</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Gandsas</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Upper gastrointestinal symptoms and associated disorders in morbidly obese patients: a prospective study</article-title>
					<source xml:lang="en">Dig Dis Sci</source>
					<year>2009</year>
					<volume>54</volume>
					<fpage>1243</fpage>
					<lpage>1246</lpage>
				</element-citation>
			</ref>
			<ref id="r12">
				<label>12</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Erim</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Cruz-Correa</surname>
							<given-names>MR</given-names>
						</name>
						<name>
							<surname>Szomstein</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Velis</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Rosenthal</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Prevalence of <named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content>seropositivity among patients undergoing bariatric surgery: a preliminary study</article-title>
					<source xml:lang="en">World J Surg</source>
					<year>2008</year>
					<volume>32</volume>
					<fpage>2021</fpage>
					<lpage>2025</lpage>
				</element-citation>
			</ref>
			<ref id="r13">
				<label>13</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Fennerty</surname>
							<given-names>MB</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Gastric intestinal metaplasia on routine endoscopic biopsy</article-title>
					<source xml:lang="en">Gastroenteroly</source>
					<year>2003</year>
					<volume>125</volume>
					<fpage>586</fpage>
					<lpage>590</lpage>
				</element-citation>
			</ref>
			<ref id="r14">
				<label>14</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Gisbert</surname>
							<given-names>JP</given-names>
						</name>
						<name>
							<surname>Blanco</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Pajares</surname>
							<given-names>JM</given-names>
						</name>
					</person-group>
					<trans-title xml:lang="en">Effect of Helicobacter pylori eradication on histological lesions of gastric mucosa. An 18-month follow-up study</trans-title>
					<source xml:lang="en">Rev Clin Esp</source>
					<year>2000</year>
					<volume>200</volume>
					<fpage>480</fpage>
					<lpage>484</lpage>
				</element-citation>
			</ref>
			<ref id="r15">
				<label>15</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Goodwin</surname>
							<given-names>CS</given-names>
						</name>
						<name>
							<surname>Armstrong</surname>
							<given-names>JA</given-names>
						</name>
						<name>
							<surname>Marshall</surname>
							<given-names>BJ</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Campylobacter pyloridis, gastritis and peptic ulceration</article-title>
					<source xml:lang="en">J Clin Pathol</source>
					<year>1986</year>
					<volume>39</volume>
					<fpage>353</fpage>
					<lpage>365</lpage>
				</element-citation>
			</ref>
			<ref id="r16">
				<label>16</label>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<collab>IARC Working Group on the Evaluation of Carcinogenic Risks to Humans</collab>
					</person-group>
					<source xml:lang="en">Schistosomoses, liver flukes and <named-content content-type="scientific-name">Helicobacter pylori</named-content>
					</source>
					<publisher-loc>Lyon, France</publisher-loc>
					<year>1994</year>
					<series>IARC monographs on the evaluation of carcinogenic risks to humans, v.61</series>
					<size units="page">270</size>
					<comment>Avaliable at
					<ext-link ext-link-type="uri" xlink:href="http://monographs.iarc.fr/ENG/Monographs/vol61/index.php">http://monographs.iarc.fr/ENG/Monographs/vol61/index.php</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="r17">
				<label>17</label>
				<element-citation publication-type="web">
					<person-group person-group-type="author">
						<collab>IARC Working Group International Agency for Research on Cancer</collab>
					</person-group>
					<publisher-loc>Lyon</publisher-loc>
					<publisher-name>International Agency for Research on Cancer</publisher-name>
					<comment>[Internet]</comment>
					<date-in-citation content-type="access-date">cited July 11, 2007</date-in-citation>
					<comment>Avaliable at
					<ext-link ext-link-type="uri" xlink:href="http://www.iarc.fr">http://www.iarc.fr</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="r18">
				<label>18</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Khitin</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Roses</surname>
							<given-names>RE</given-names>
						</name>
						<name>
							<surname>Birkett</surname>
							<given-names>DH</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Cancer in the gastric remnant after gastric bypass: a case report</article-title>
					<source xml:lang="en">Curr Surg</source>
					<year>2003</year>
					<volume>60</volume>
					<fpage>521</fpage>
					<lpage>523</lpage>
				</element-citation>
			</ref>
			<ref id="r19">
				<label>19</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lee</surname>
							<given-names>WJ</given-names>
						</name>
						<name>
							<surname>Wang</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Lin</surname>
							<given-names>CM</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>TC</given-names>
						</name>
						<name>
							<surname>Wei</surname>
							<given-names>PL</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Seroprevalence of <named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content>in morbidly obese patients</article-title>
					<source xml:lang="en">Surg Obes Relat Dis</source>
					<year>2005</year>
					<volume>1</volume>
					<issue>3</issue>
					<fpage>258</fpage>
				</element-citation>
			</ref>
			<ref id="r20">
				<label>20</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Leung</surname>
							<given-names>WK</given-names>
						</name>
						<name>
							<surname>Lin</surname>
							<given-names>SR</given-names>
						</name>
						<name>
							<surname>Ching</surname>
							<given-names>JY</given-names>
						</name>
						<name>
							<surname>To</surname>
							<given-names>KF</given-names>
						</name>
						<name>
							<surname>Ng</surname>
							<given-names>EK</given-names>
						</name>
						<name>
							<surname>Chan</surname>
							<given-names>FK</given-names>
						</name>
						<name>
							<surname>Lau</surname>
							<given-names>JY</given-names>
						</name>
						<name>
							<surname>Sung</surname>
							<given-names>JJ</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Factors predicting progression of gastric intestinal metaplasia: results of a randomized trial on <named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content>eradication</article-title>
					<source xml:lang="en">Gut</source>
					<year>2004</year>
					<volume>53</volume>
					<fpage>1244</fpage>
					<lpage>1249</lpage>
				</element-citation>
			</ref>
			<ref id="r21">
				<label>21</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lord</surname>
							<given-names>RV</given-names>
						</name>
						<name>
							<surname>Edwards</surname>
							<given-names>PD</given-names>
						</name>
						<name>
							<surname>Coleman</surname>
							<given-names>MJ</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Gastric cancer in the bypassed segment after operation for morbid obesity</article-title>
					<source xml:lang="en">Aust N Z J Surg</source>
					<year>1997</year>
					<volume>67</volume>
					<fpage>580</fpage>
					<lpage>582</lpage>
				</element-citation>
			</ref>
			<ref id="r22">
				<label>22</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lu</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>MT</given-names>
						</name>
						<name>
							<surname>Fan</surname>
							<given-names>YH</given-names>
						</name>
						<name>
							<surname>Liu</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Meng</surname>
							<given-names>LN</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Effects of <named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content> eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study</article-title>
					<source xml:lang="en">World J Gastroenterol</source>
					<year>2005</year>
					<volume>11</volume>
					<fpage>6518</fpage>
					<lpage>6520</lpage>
				</element-citation>
			</ref>
			<ref id="r23">
				<label>23</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Madan</surname>
							<given-names>AK</given-names>
						</name>
						<name>
							<surname>Speck</surname>
							<given-names>KE</given-names>
						</name>
						<name>
							<surname>Hiler</surname>
							<given-names>ML</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Routine preoperative upper endoscopy for laparoscopic gastric bypass: is it necessary?</article-title>
					<source xml:lang="en">Am Surg</source>
					<year>2004</year>
					<volume>70</volume>
					<fpage>684</fpage>
					<lpage>686</lpage>
				</element-citation>
			</ref>
			<ref id="r24">
				<label>24</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Malfertheiner</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Sipponen</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Naumann</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Moayyedi</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Mégraud</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Xiao</surname>
							<given-names>SD</given-names>
						</name>
						<name>
							<surname>Sugano</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Nyrén</surname>
							<given-names>O</given-names>
						</name>
						<name>
							<surname>Lejondal</surname>
							<given-names>H</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">pylori-Gastric Cancer Task Force. <named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content>eradication has the potential to prevent gastric cancer: a state-of-the-art critique</article-title>
					<source xml:lang="en">Am J Gastroenterol</source>
					<year>2005</year>
					<volume>100</volume>
					<fpage>2100</fpage>
					<lpage>2115</lpage>
				</element-citation>
			</ref>
			<ref id="r25">
				<label>25</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mong</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Van Dam</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Morton</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Gerson</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Curet</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Banerjee</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Preoperative endoscopic screening for laparoscopic Roux-en-Y gastric bypass has a low yield for anatomic findings</article-title>
					<source xml:lang="en">Obes Surg</source>
					<year>2008</year>
					<volume>18</volume>
					<fpage>1067</fpage>
					<lpage>1073</lpage>
				</element-citation>
			</ref>
			<ref id="r26">
				<label>26</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Muñoz</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Ibáñez</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Salinas</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Escalona</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Pérez</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Pimentel</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Guzmán</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Boza</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Importance of routine preoperative upper GI endoscopy: why all patients should be evaluated? </article-title>
					<source xml:lang="en">Obes Surg</source>
					<year>2009</year>
					<volume>19</volume>
					<fpage>427</fpage>
					<lpage>431</lpage>
				</element-citation>
			</ref>
			<ref id="r27">
				<label>27</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Nomura</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Stemmermann</surname>
							<given-names>GN</given-names>
						</name>
						<name>
							<surname>Chyou</surname>
							<given-names>PH</given-names>
						</name>
						<name>
							<surname>Kato</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Perez-Perez</surname>
							<given-names>GI</given-names>
						</name>
						<name>
							<surname>Blaser</surname>
							<given-names>MJ</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">
						<named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content> infection and gastric carcinoma among Japanese Americans in Hawaii</article-title>
					<source xml:lang="en">N Engl J Med</source>
					<year>1991</year>
					<volume>325</volume>
					<fpage>1132</fpage>
					<lpage>1136</lpage>
				</element-citation>
			</ref>
			<ref id="r28">
				<label>28</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ohata</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Kitauchi</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Yoshimura</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Mugitani</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Iwane</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Nakamura</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Yoshikawa</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Yanaoka</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Arii</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Tamai</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Shimizu</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Takeshita</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Mohara</surname>
							<given-names>O</given-names>
						</name>
						<name>
							<surname>Ichinose</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Progression of chronic atrophic gastritis associated with <named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content> infection increases risk of gastric cancer</article-title>
					<source xml:lang="en">Int J Cancer</source>
					<year>2004</year>
					<volume>109</volume>
					<fpage>138</fpage>
					<lpage>143</lpage>
				</element-citation>
			</ref>
			<ref id="r29">
				<label>29</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>O'Mahony</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Erim</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Szomstein</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Rosenthal</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Prevalence of <named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content> infection among patients undergoing bariatric surgery</article-title>
					<source xml:lang="en">Surg Obes Relat Dis</source>
					<year>2006</year>
					<volume>2</volume>
					<issue>3</issue>
					<fpage>303</fpage>
				</element-citation>
			</ref>
			<ref id="r30">
				<label>30</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Papasavas</surname>
							<given-names>PK</given-names>
						</name>
						<name>
							<surname>Gagné</surname>
							<given-names>DJ</given-names>
						</name>
						<name>
							<surname>Donnelly</surname>
							<given-names>PE</given-names>
						</name>
						<name>
							<surname>Salgado</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Urbandt</surname>
							<given-names>JE</given-names>
						</name>
						<name>
							<surname>Burton</surname>
							<given-names>KK</given-names>
						</name>
						<name>
							<surname>Caushaj</surname>
							<given-names>PF</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Prevalence of <named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content> infection and value of preoperative testing and treatment in patients undergoing laparoscopic Roux-en-Y gastric bypass</article-title>
					<source xml:lang="en">Surg Obes Relat Dis</source>
					<year>2008</year>
					<volume>4</volume>
					<fpage>383</fpage>
					<lpage>388</lpage>
				</element-citation>
			</ref>
			<ref id="r31">
				<label>31</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Parsonnet</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Friedman</surname>
							<given-names>GD</given-names>
						</name>
						<name>
							<surname>Vandersteen</surname>
							<given-names>DP</given-names>
						</name>
						<name>
							<surname>Chang</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Volgeman</surname>
							<given-names>JH</given-names>
						</name>
						<name>
							<surname>Orentreich</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Sibley</surname>
							<given-names>RK</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">
						<named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content> infection and the risk of gastric carcinoma</article-title>
					<source xml:lang="en">N Engl J Med</source>
					<year>1991</year>
					<volume>325</volume>
					<fpage>1127</fpage>
					<lpage>1131</lpage>
				</element-citation>
			</ref>
			<ref id="r32">
				<label>32</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Renshaw</surname>
							<given-names>AA</given-names>
						</name>
						<name>
							<surname>Rabaza</surname>
							<given-names>JR</given-names>
						</name>
						<name>
							<surname>Gonzalez</surname>
							<given-names>AM</given-names>
						</name>
						<name>
							<surname>Verdeja</surname>
							<given-names>JC</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">
						<named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content> infection in patients undergoing gastric bypass surgery for morbid obesity</article-title>
					<source xml:lang="en">Obes Surg</source>
					<year>2001</year>
					<volume>11</volume>
					<fpage>281</fpage>
					<lpage>283</lpage>
				</element-citation>
			</ref>
			<ref id="r33">
				<label>33</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Safatle-Ribeiro</surname>
							<given-names>AV</given-names>
						</name>
						<name>
							<surname>Kuga</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Iriya</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Ribeiro U</surname>
							<given-names>Jr</given-names>
						</name>
						<name>
							<surname>Faintuch</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Ishida</surname>
							<given-names>RK</given-names>
						</name>
						<name>
							<surname>Corbett</surname>
							<given-names>CE</given-names>
						</name>
						<name>
							<surname>Garrido AB</surname>
							<given-names>Jr</given-names>
						</name>
						<name>
							<surname>Ishioka</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Sakai</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">What to expect in the excluded stomach mucosa after vertical banded Roux-en-Y gastric bypass for morbid obesity</article-title>
					<source xml:lang="en">J Gastrointest Surg</source>
					<year>2007</year>
					<volume>11</volume>
					<fpage>133</fpage>
					<lpage>137</lpage>
				</element-citation>
			</ref>
			<ref id="r34">
				<label>34</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sauerland</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Angrisani</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Belachew</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Chevallier</surname>
							<given-names>JM</given-names>
						</name>
						<name>
							<surname>Favretti</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Finer</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Fingerhut</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Garcia Caballero</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Guisado Macias</surname>
							<given-names>JA</given-names>
						</name>
						<name>
							<surname>Mittermair</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Morino</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Msika</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Rubino</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Tacchino</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Weiner</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Neugebauer</surname>
							<given-names>EA</given-names>
						</name>
						<collab>European Association for Endoscopic Surgery</collab>
					</person-group>
					<article-title xml:lang="en">Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES) </article-title>
					<source xml:lang="en">Surg Endosc</source>
					<year>2005</year>
					<volume>19</volume>
					<fpage>200</fpage>
					<lpage>221</lpage>
				</element-citation>
			</ref>
			<ref id="r35">
				<label>35</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sharaf</surname>
							<given-names>RN</given-names>
						</name>
						<name>
							<surname>Weinshel</surname>
							<given-names>EH</given-names>
						</name>
						<name>
							<surname>Bini</surname>
							<given-names>EJ</given-names>
						</name>
						<name>
							<surname>Rosenberg</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Sherman</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Ren</surname>
							<given-names>CJ</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Endoscopy plays an important preoperative role in bariatric surgery</article-title>
					<source xml:lang="en">Obes Surg</source>
					<year>2004</year>
					<volume>14</volume>
					<fpage>1367</fpage>
					<lpage>1372</lpage>
				</element-citation>
			</ref>
			<ref id="r36">
				<label>36</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Trincado</surname>
							<given-names>MT</given-names>
						</name>
						<name>
							<surname>del Olmo</surname>
							<given-names>JC</given-names>
						</name>
						<name>
							<surname>García Castaño</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Cuesta</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Blanco</surname>
							<given-names>JI</given-names>
						</name>
						<name>
							<surname>Awad</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Carbajo</surname>
							<given-names>MA</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Gastric pouch carcinoma after gastric bypass for morbid obesity</article-title>
					<source xml:lang="en">Obes Surg</source>
					<year>2005</year>
					<volume>15</volume>
					<fpage>1215</fpage>
					<lpage>1217</lpage>
				</element-citation>
			</ref>
			<ref id="r37">
				<label>37</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Uemura</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Okamoto</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Yamamoto</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Matsumura</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Yamaguchi</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Yamakido</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Taniyama</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Sasaki</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Schlemper</surname>
							<given-names>RJ</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">
						<named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content>infection and the development of gastric cancer</article-title>
					<source xml:lang="en">N Engl J Med</source>
					<year>2001</year>
					<volume>345</volume>
					<fpage>784</fpage>
					<lpage>789</lpage>
				</element-citation>
			</ref>
			<ref id="r38">
				<label>38</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Vanek</surname>
							<given-names>VW</given-names>
						</name>
						<name>
							<surname>Catania</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Triveri</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Woodruff RW</surname>
							<given-names>Jr.</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Retrospective review of the preoperative biliary and gastrointestinal evaluation for gastric bypass surgery</article-title>
					<source xml:lang="en">Surg Obes Relat Dis</source>
					<year>2006</year>
					<volume>2</volume>
					<page-range>17-22;discussion 22-3</page-range>
				</element-citation>
			</ref>
			<ref id="r39">
				<label>39</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Voellinger</surname>
							<given-names>DC</given-names>
						</name>
						<name>
							<surname>Inabnet</surname>
							<given-names>WB</given-names>
						</name>
					</person-group>
					<article-title xml:lang="en">Laparoscopic Roux-en-Y gastric bypass with remnant gastrectomy for focal intestinal metaplasia of the gastric antrum</article-title>
					<source xml:lang="en">Obes Surg</source>
					<year>2002</year>
					<volume>12</volume>
					<fpage>695</fpage>
					<lpage>698</lpage>
				</element-citation>
			</ref>
			<ref id="r40">
				<label>40</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Wong</surname>
							<given-names>BC</given-names>
						</name>
						<name>
							<surname>Lam</surname>
							<given-names>SK</given-names>
						</name>
						<name>
							<surname>Wong</surname>
							<given-names>WM</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>JS</given-names>
						</name>
						<name>
							<surname>Zheng</surname>
							<given-names>TT</given-names>
						</name>
						<name>
							<surname>Feng</surname>
							<given-names>RE</given-names>
						</name>
						<name>
							<surname>Lai</surname>
							<given-names>KC</given-names>
						</name>
						<name>
							<surname>Hu</surname>
							<given-names>WH</given-names>
						</name>
						<name>
							<surname>Yuen</surname>
							<given-names>ST</given-names>
						</name>
						<name>
							<surname>Leung</surname>
							<given-names>SY</given-names>
						</name>
						<name>
							<surname>Fong</surname>
							<given-names>DY</given-names>
						</name>
						<name>
							<surname>Ho</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Ching</surname>
							<given-names>CK</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>JS</given-names>
						</name>
						<collab>China Gastric Cancer Study Group</collab>
					</person-group>
					<article-title xml:lang="en">
						<named-content content-type="scientific-name">
							<italic>Helicobacter</italic>
							<italic>pylori</italic>
						</named-content>eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial</article-title>
					<source xml:lang="en">JAMA</source>
					<year>2004</year>
					<volume>291</volume>
					<fpage>187</fpage>
					<lpage>194</lpage>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="other">
				<p>Hospital Nossa Sra. da Conceição (HNSC), Class III Obesity Care Center, Porto Alegre, RS, Brazil</p>
			</fn>
		</fn-group>
	</back>
</article>
